In vitro, GBM CSC proliferation was induced either by treatment with exogenous CXCL12 (Liu et al., 2013) or by the receptor activation induced by CXCL12 secreted by CSCs in an autocrine fashion (Uemae et al., 2014). This evidence concerns the gene CXCL12 and glioblastoma.